- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.40 Å
- Oligo State
- hetero-4-4-4-mer
- Ligands
- 4 x CO: COBALT (II) ION(Non-covalent)
- 4 x F09: NONAN-1-OL(Non-covalent)
F09.2: 4 residues within 4Å:- Chain A: R.57
- Chain C: L.46, W.87, V.94
4 PLIP interactions:3 interactions with chain C, 1 interactions with chain A- Hydrophobic interactions: C:L.46, C:W.87, C:V.94
- Hydrogen bonds: A:R.57
F09.13: 4 residues within 4Å:- Chain D: R.57
- Chain F: L.46, W.87, V.94
4 PLIP interactions:3 interactions with chain F, 1 interactions with chain D- Hydrophobic interactions: F:L.46, F:W.87, F:V.94
- Hydrogen bonds: D:R.57
F09.24: 4 residues within 4Å:- Chain G: R.57
- Chain I: L.46, W.87, V.94
4 PLIP interactions:3 interactions with chain I, 1 interactions with chain G- Hydrophobic interactions: I:L.46, I:W.87, I:V.94
- Hydrogen bonds: G:R.57
F09.35: 4 residues within 4Å:- Chain J: R.57
- Chain L: L.46, W.87, V.94
4 PLIP interactions:3 interactions with chain L, 1 interactions with chain J- Hydrophobic interactions: L:L.46, L:W.87, L:V.94
- Hydrogen bonds: J:R.57
- 4 x DGA: DIACYL GLYCEROL(Non-covalent)
DGA.3: 9 residues within 4Å:- Chain C: L.86, R.89
- Chain L: L.41, S.44, Y.45, Y.62, P.63, L.66, V.70
5 PLIP interactions:3 interactions with chain L, 2 interactions with chain C- Hydrophobic interactions: L:Y.45, L:Y.62, L:V.70
- Water bridges: C:R.89
- Salt bridges: C:R.89
DGA.14: 9 residues within 4Å:- Chain C: L.41, S.44, Y.45, Y.62, P.63, L.66, V.70
- Chain F: L.86, R.89
5 PLIP interactions:3 interactions with chain C, 2 interactions with chain F- Hydrophobic interactions: C:Y.45, C:Y.62, C:V.70
- Water bridges: F:R.89
- Salt bridges: F:R.89
DGA.25: 9 residues within 4Å:- Chain F: L.41, S.44, Y.45, Y.62, P.63, L.66, V.70
- Chain I: L.86, R.89
5 PLIP interactions:3 interactions with chain F, 2 interactions with chain I- Hydrophobic interactions: F:Y.45, F:Y.62, F:V.70
- Water bridges: I:R.89
- Salt bridges: I:R.89
DGA.36: 9 residues within 4Å:- Chain I: L.41, S.44, Y.45, Y.62, P.63, L.66, V.70
- Chain L: L.86, R.89
5 PLIP interactions:3 interactions with chain I, 2 interactions with chain L- Hydrophobic interactions: I:Y.45, I:Y.62, I:V.70
- Water bridges: L:R.89
- Salt bridges: L:R.89
- 4 x HX0: N,N,N-trioctyloctan-1-aminium
HX0.4: 27 residues within 4Å:- Chain C: L.36, A.73, T.74, T.75, G.99, F.103
- Chain F: L.36, A.73, T.74, T.75, G.99, F.103
- Chain I: L.36, A.73, T.74, T.75, G.99, F.103
- Chain L: L.36, A.73, T.74, T.75, G.99, F.103
- Ligands: HX0.15, HX0.26, HX0.37
10 PLIP interactions:2 interactions with chain I, 3 interactions with chain L, 3 interactions with chain F, 2 interactions with chain C- Hydrophobic interactions: I:L.36, I:F.103, L:L.36, L:F.103, L:F.103, F:L.36, F:F.103, F:F.103, C:L.36, C:F.103
HX0.15: 27 residues within 4Å:- Chain C: L.36, A.73, T.74, T.75, G.99, F.103
- Chain F: L.36, A.73, T.74, T.75, G.99, F.103
- Chain I: L.36, A.73, T.74, T.75, G.99, F.103
- Chain L: L.36, A.73, T.74, T.75, G.99, F.103
- Ligands: HX0.4, HX0.26, HX0.37
10 PLIP interactions:3 interactions with chain I, 2 interactions with chain L, 2 interactions with chain F, 3 interactions with chain C- Hydrophobic interactions: I:L.36, I:F.103, I:F.103, L:L.36, L:F.103, F:L.36, F:F.103, C:L.36, C:F.103, C:F.103
HX0.26: 27 residues within 4Å:- Chain C: L.36, A.73, T.74, T.75, G.99, F.103
- Chain F: L.36, A.73, T.74, T.75, G.99, F.103
- Chain I: L.36, A.73, T.74, T.75, G.99, F.103
- Chain L: L.36, A.73, T.74, T.75, G.99, F.103
- Ligands: HX0.4, HX0.15, HX0.37
10 PLIP interactions:2 interactions with chain I, 3 interactions with chain L, 3 interactions with chain F, 2 interactions with chain C- Hydrophobic interactions: I:L.36, I:F.103, L:L.36, L:F.103, L:F.103, F:L.36, F:F.103, F:F.103, C:L.36, C:F.103
HX0.37: 27 residues within 4Å:- Chain C: L.36, A.73, T.74, T.75, G.99, F.103
- Chain F: L.36, A.73, T.74, T.75, G.99, F.103
- Chain I: L.36, A.73, T.74, T.75, G.99, F.103
- Chain L: L.36, A.73, T.74, T.75, G.99, F.103
- Ligands: HX0.4, HX0.15, HX0.26
10 PLIP interactions:2 interactions with chain L, 2 interactions with chain F, 3 interactions with chain I, 3 interactions with chain C- Hydrophobic interactions: L:L.36, L:F.103, F:L.36, F:F.103, I:L.36, I:F.103, I:F.103, C:L.36, C:F.103, C:F.103
- 28 x K: POTASSIUM ION(Non-covalent)
K.5: 19 residues within 4Å:- Chain C: T.75
- Chain F: T.75
- Chain I: T.75
- Chain L: T.75
- Ligands: K.7, K.8, K.9, K.16, K.18, K.19, K.20, K.27, K.29, K.30, K.31, K.38, K.40, K.41, K.42
Ligand excluded by PLIPK.6: 19 residues within 4Å:- Chain C: G.77, Y.78
- Chain F: G.77, Y.78
- Chain I: G.77, Y.78
- Chain L: G.77, Y.78
- Ligands: K.10, K.11, K.17, K.21, K.22, K.28, K.32, K.33, K.39, K.43, K.44
Ligand excluded by PLIPK.7: 31 residues within 4Å:- Chain C: T.75, V.76, G.77
- Chain F: T.75, V.76, G.77
- Chain I: T.75, V.76, G.77
- Chain L: T.75, V.76, G.77
- Ligands: K.5, K.8, K.9, K.11, K.16, K.18, K.19, K.20, K.22, K.27, K.29, K.30, K.31, K.33, K.38, K.40, K.41, K.42, K.44
Ligand excluded by PLIPK.8: 23 residues within 4Å:- Chain C: T.75, G.77
- Chain F: T.75, G.77
- Chain I: T.75, G.77
- Chain L: T.75, G.77
- Ligands: K.5, K.7, K.9, K.16, K.18, K.19, K.20, K.27, K.29, K.30, K.31, K.38, K.40, K.41, K.42
Ligand excluded by PLIPK.9: 19 residues within 4Å:- Chain C: T.75
- Chain F: T.75
- Chain I: T.75
- Chain L: T.75
- Ligands: K.5, K.7, K.8, K.16, K.18, K.19, K.20, K.27, K.29, K.30, K.31, K.38, K.40, K.41, K.42
Ligand excluded by PLIPK.10: 19 residues within 4Å:- Chain C: G.77, Y.78
- Chain F: G.77, Y.78
- Chain I: G.77, Y.78
- Chain L: G.77, Y.78
- Ligands: K.6, K.11, K.17, K.21, K.22, K.28, K.32, K.33, K.39, K.43, K.44
Ligand excluded by PLIPK.11: 19 residues within 4Å:- Chain C: G.77
- Chain F: G.77
- Chain I: G.77
- Chain L: G.77
- Ligands: K.6, K.7, K.10, K.17, K.18, K.21, K.22, K.28, K.29, K.32, K.33, K.39, K.40, K.43, K.44
Ligand excluded by PLIPK.16: 19 residues within 4Å:- Chain C: T.75
- Chain F: T.75
- Chain I: T.75
- Chain L: T.75
- Ligands: K.5, K.7, K.8, K.9, K.18, K.19, K.20, K.27, K.29, K.30, K.31, K.38, K.40, K.41, K.42
Ligand excluded by PLIPK.17: 19 residues within 4Å:- Chain C: G.77, Y.78
- Chain F: G.77, Y.78
- Chain I: G.77, Y.78
- Chain L: G.77, Y.78
- Ligands: K.6, K.10, K.11, K.21, K.22, K.28, K.32, K.33, K.39, K.43, K.44
Ligand excluded by PLIPK.18: 31 residues within 4Å:- Chain C: T.75, V.76, G.77
- Chain F: T.75, V.76, G.77
- Chain I: T.75, V.76, G.77
- Chain L: T.75, V.76, G.77
- Ligands: K.5, K.7, K.8, K.9, K.11, K.16, K.19, K.20, K.22, K.27, K.29, K.30, K.31, K.33, K.38, K.40, K.41, K.42, K.44
Ligand excluded by PLIPK.19: 23 residues within 4Å:- Chain C: T.75, G.77
- Chain F: T.75, G.77
- Chain I: T.75, G.77
- Chain L: T.75, G.77
- Ligands: K.5, K.7, K.8, K.9, K.16, K.18, K.20, K.27, K.29, K.30, K.31, K.38, K.40, K.41, K.42
Ligand excluded by PLIPK.20: 19 residues within 4Å:- Chain C: T.75
- Chain F: T.75
- Chain I: T.75
- Chain L: T.75
- Ligands: K.5, K.7, K.8, K.9, K.16, K.18, K.19, K.27, K.29, K.30, K.31, K.38, K.40, K.41, K.42
Ligand excluded by PLIPK.21: 19 residues within 4Å:- Chain C: G.77, Y.78
- Chain F: G.77, Y.78
- Chain I: G.77, Y.78
- Chain L: G.77, Y.78
- Ligands: K.6, K.10, K.11, K.17, K.22, K.28, K.32, K.33, K.39, K.43, K.44
Ligand excluded by PLIPK.22: 19 residues within 4Å:- Chain C: G.77
- Chain F: G.77
- Chain I: G.77
- Chain L: G.77
- Ligands: K.6, K.7, K.10, K.11, K.17, K.18, K.21, K.28, K.29, K.32, K.33, K.39, K.40, K.43, K.44
Ligand excluded by PLIPK.27: 19 residues within 4Å:- Chain C: T.75
- Chain F: T.75
- Chain I: T.75
- Chain L: T.75
- Ligands: K.5, K.7, K.8, K.9, K.16, K.18, K.19, K.20, K.29, K.30, K.31, K.38, K.40, K.41, K.42
Ligand excluded by PLIPK.28: 19 residues within 4Å:- Chain C: G.77, Y.78
- Chain F: G.77, Y.78
- Chain I: G.77, Y.78
- Chain L: G.77, Y.78
- Ligands: K.6, K.10, K.11, K.17, K.21, K.22, K.32, K.33, K.39, K.43, K.44
Ligand excluded by PLIPK.29: 31 residues within 4Å:- Chain C: T.75, V.76, G.77
- Chain F: T.75, V.76, G.77
- Chain I: T.75, V.76, G.77
- Chain L: T.75, V.76, G.77
- Ligands: K.5, K.7, K.8, K.9, K.11, K.16, K.18, K.19, K.20, K.22, K.27, K.30, K.31, K.33, K.38, K.40, K.41, K.42, K.44
Ligand excluded by PLIPK.30: 23 residues within 4Å:- Chain C: T.75, G.77
- Chain F: T.75, G.77
- Chain I: T.75, G.77
- Chain L: T.75, G.77
- Ligands: K.5, K.7, K.8, K.9, K.16, K.18, K.19, K.20, K.27, K.29, K.31, K.38, K.40, K.41, K.42
Ligand excluded by PLIPK.31: 19 residues within 4Å:- Chain C: T.75
- Chain F: T.75
- Chain I: T.75
- Chain L: T.75
- Ligands: K.5, K.7, K.8, K.9, K.16, K.18, K.19, K.20, K.27, K.29, K.30, K.38, K.40, K.41, K.42
Ligand excluded by PLIPK.32: 19 residues within 4Å:- Chain C: G.77, Y.78
- Chain F: G.77, Y.78
- Chain I: G.77, Y.78
- Chain L: G.77, Y.78
- Ligands: K.6, K.10, K.11, K.17, K.21, K.22, K.28, K.33, K.39, K.43, K.44
Ligand excluded by PLIPK.33: 19 residues within 4Å:- Chain C: G.77
- Chain F: G.77
- Chain I: G.77
- Chain L: G.77
- Ligands: K.6, K.7, K.10, K.11, K.17, K.18, K.21, K.22, K.28, K.29, K.32, K.39, K.40, K.43, K.44
Ligand excluded by PLIPK.38: 19 residues within 4Å:- Chain C: T.75
- Chain F: T.75
- Chain I: T.75
- Chain L: T.75
- Ligands: K.5, K.7, K.8, K.9, K.16, K.18, K.19, K.20, K.27, K.29, K.30, K.31, K.40, K.41, K.42
Ligand excluded by PLIPK.39: 19 residues within 4Å:- Chain C: G.77, Y.78
- Chain F: G.77, Y.78
- Chain I: G.77, Y.78
- Chain L: G.77, Y.78
- Ligands: K.6, K.10, K.11, K.17, K.21, K.22, K.28, K.32, K.33, K.43, K.44
Ligand excluded by PLIPK.40: 31 residues within 4Å:- Chain C: T.75, V.76, G.77
- Chain F: T.75, V.76, G.77
- Chain I: T.75, V.76, G.77
- Chain L: T.75, V.76, G.77
- Ligands: K.5, K.7, K.8, K.9, K.11, K.16, K.18, K.19, K.20, K.22, K.27, K.29, K.30, K.31, K.33, K.38, K.41, K.42, K.44
Ligand excluded by PLIPK.41: 23 residues within 4Å:- Chain C: T.75, G.77
- Chain F: T.75, G.77
- Chain I: T.75, G.77
- Chain L: T.75, G.77
- Ligands: K.5, K.7, K.8, K.9, K.16, K.18, K.19, K.20, K.27, K.29, K.30, K.31, K.38, K.40, K.42
Ligand excluded by PLIPK.42: 19 residues within 4Å:- Chain C: T.75
- Chain F: T.75
- Chain I: T.75
- Chain L: T.75
- Ligands: K.5, K.7, K.8, K.9, K.16, K.18, K.19, K.20, K.27, K.29, K.30, K.31, K.38, K.40, K.41
Ligand excluded by PLIPK.43: 19 residues within 4Å:- Chain C: G.77, Y.78
- Chain F: G.77, Y.78
- Chain I: G.77, Y.78
- Chain L: G.77, Y.78
- Ligands: K.6, K.10, K.11, K.17, K.21, K.22, K.28, K.32, K.33, K.39, K.44
Ligand excluded by PLIPK.44: 19 residues within 4Å:- Chain C: G.77
- Chain F: G.77
- Chain I: G.77
- Chain L: G.77
- Ligands: K.6, K.7, K.10, K.11, K.17, K.18, K.21, K.22, K.28, K.29, K.32, K.33, K.39, K.40, K.43
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Lenaeus, M.J. et al., Structures of Kcsa in Complex with Symmetrical Quaternary Ammonium Compounds Reveal a Hydrophobic Binding Site. Biochemistry (2014)
- Release Date
- 2009-11-17
- Peptides
- ANTIBODY FAB FRAGMENT LIGHT CHAIN: ADGJ
ANTIBODY FAB FRAGMENT HEAVY CHAIN: BEHK
VOLTAGE-GATED POTASSIUM CHANNEL: CFIL - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AD
AG
AJ
AB
BE
BH
BK
BC
CF
CI
CL
C - Membrane
-
We predict this structure to be a membrane protein.
SMTL ID : 2w0f.1
Potassium Channel KcsA-Fab Complex with Tetraoctylammonium
ANTIBODY FAB FRAGMENT LIGHT CHAIN
Toggle Identical (ADGJ)ANTIBODY FAB FRAGMENT HEAVY CHAIN
Toggle Identical (BEHK)VOLTAGE-GATED POTASSIUM CHANNEL
Toggle Identical (CFIL)Related Entries With Identical Sequence
1k4c.1 | 1k4d.1 | 1r3i.1 | 1r3j.1 | 1r3k.1 | 1r3l.1 | 1s5h.1 | 1zwi.1 | 2atk.1 | 2bob.1 | 2boc.1 | 2dwd.1 | 2dwe.1 | 2h8p.1 | 2hfe.1 | 2hg5.1 | 2hjf.1 | 2hvj.1 | 2hvk.1 | 2ih1.1 | 2ih3.1 | 2itc.1 | 2itd.1 | 2jk5.1 | 2nlj.1 | 2p7t.2 | 2p7t.3 | 3f5w.1 | 3f7v.1 | 3f7v.2 more...less...3f7y.1 | 3f7y.2 | 3fb5.1 | 3fb5.2 | 3fb6.1 | 3fb6.2 | 3fb7.1 | 3fb7.2 | 3fb8.1 | 3fb8.2 | 3fb8.3 | 3gb7.1 | 3hpl.1 | 3iga.1 | 3ogc.1 | 3or6.1 | 3or7.1 | 3stl.1 | 3stz.1 | 4lbe.1 | 4lcu.1 | 4msw.1 | 4uuj.1 | 5e1a.1 | 5ebl.1 | 5ebm.1 | 5ec1.1 | 5ec2.1 | 5j9p.1 | 5vk6.1 | 5vke.1 | 5vkh.1 | 6by2.1 | 6by3.1 | 6nfu.1 | 6nfv.1 | 6pa0.1 | 6w0a.1 | 6w0b.1 | 6w0c.1 | 6w0d.1 | 6w0e.1 | 6w0f.1 | 6w0g.1 | 6w0h.1 | 6w0i.1 | 6w0j.1 | 7m2h.1 | 7m2h.2 | 7m2i.1 | 7m2j.1 | 7mhr.1 | 7mhx.1 | 7rp0.1 | 7sqw.1 | 8thn.1